Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tengfu Jiangya tablets plus valsartan + amlodipine for grade 2 primary hypertension
ChiCTR2000030611Phase 2Recruiting
- Sponsor
- Affiliated Hospital of Shandong University of Traditional Chinese Medicine
- Start
- Jul 2020
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Tengfu Jiangya tablets in essential hypertension (2 arms), sponsored by Affiliated Hospital of Shandong University of Traditional Chinese Medicine. Primary endpoints: TCM syndrome score, Blood pressure and 6 more. Started Jul 2020; status: recruiting.
02
Drugs
Tengfu Jiangya tablets
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ChiCTR2000030611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030611.